Flow-induced vasodilation in hamster cremasteric arterioles was investigated with special reference to the roles of nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). Arterioles (∼60 µm resting diameter) were cannulated, and suffused with MOPS solution at 37°C (mean intraluminal pressure: 80 cm H2O). Step increases in the perfusate flow elicited a dose-dependent vasodilation, which was almost proportional to the increases in calculated wall shear stress (WSS). Nω-nitro L-arginine methyl ester (L-NAME, 100 µM) reduced the flow-induced vasodilation by ∼50%, whereas indomethacin (10 µM) produced no significant effect. In the presence of L-NAME, the residual vasodilation was eliminated by treatment with the cytochrome P-450 monooxygenase inhibitor 17-octadecynoic acid (17-ODYA, 50 µM), sulfaphenazol (10 µM), tetraethylammonium (TEA, 3 mM; a nonselective Ca2+-activated K+ channel inhibitor), or charybdotoxin (ChTX, 0.1 µM; intermediate or large conductance Ca2+-activated K+ channel inhibitor). In the absence of L-NAME, the dilation was also reduced by ∼50% by treatment with 17-ODYA, TEA, or ChTX. The residual vasodilation was eliminated by additional treatment with L-NAME. The inhibitor of ATP-sensitive K+ channels (KATP), glibenclamide, also caused a significant, but partial, reduction of the flow-induced vasodilation. The residual vasodilation was completely reduced by additional treatment with 17-ODYA, but not L-NAME. These findings suggest that in hamster cremaster, higher flow rate produces NO, KATP, and EDHF vasodilation of the arterioles under physiological conditions.

1.
Dube S, Canty JM Jr: Shear stress-induced vasodilation in porcine coronary conduit arteries is independent of nitric oxide release. Am J Physiol Heart Circ Physiol 2001;280:H2581–H2590.
2.
Huang A, Sun D, Carroll MA, Jiang H, Smith CJ, Connetta JA, Falck JR, Shesely EG, Koller A, Kaley G: EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. Am J Physiol Heart Circ Physiol 2001;280:H2462–H2469.
3.
Koller A, Kaley G: Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circ Res 1990;67:529–534.
4.
Koller A, Kaley G: Endothelial regulation of wall shear stress and blood flow in skeletal muscle microcirculation. Am J Physiol Heart Circ Physiol 1991;260:H862–H868.
5.
Koller A, Sun D, Huang A, Kaley G: Corelease of nitric oxide and prostaglandins mediates flow-dependent dilation of rat gracilis muscle arterioles. Am J Physiol Heart Circ Physiol 1994;267:H326–H332.
6.
Koller A, Sun D, Kaley G: Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993;72:1276–1284.
7.
Kuo L, Chilian WM, Davis MJ: Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol Heart Circ Physiol 1991;261:H1706–H1715.
8.
Kuo L, Davis MJ, Chilian WM: Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol Heart Circ Physiol 1990;259:H1063–H1070.
9.
Sun D, Huang A, Koller A, Kaley G: Endothelial KCa channels mediate flow-dependent dilation of arterioles of skeletal muscle and mesentery. Microvasc Res 2001;61:179–186.
10.
Takamura Y, Shimokawa H, Zhao H, Igarashi H, Egashira K, Takeshita A: Important role of endothelium-derived hyperpolarizing factor in shear stress-induced endothelium-dependent relaxations in the rat mesenteric artery. J Cardiovasc Pharmacol 1999;34:381–387.
11.
Garcia-Roldan JL, Bevan JA: Flow-induced constriction and dilation of cerebral resistance arteries. Circ Res 1990;66:1445–1448.
12.
Ngai AC, Winn HR: Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res 1995;77:832–840.
13.
Bryan RM Jr, Marrelli SP, Steenberg ML, Schildmeyer LA, Johnson TD: Effects of luminal shear stress on cerebral arteries and arterioles. Am J Physiol Heart Circ Physiol 2001;280:H2011–H2022.
14.
De Wit C, Schafer C, von Bismarck P, Bolz SS, Pohl U: Elevation of plasma viscosity induces sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo. Pflügers Arch 1997;434:354–361.
15.
McGahren ED, Dora KA, Damon DN, Duling BR: A test of the role of flow-dependent dilation in arteriolar responses to occlusion. Am J Physiol Heart Circ Physiol 1997;272:H714–H721.
16.
Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R: Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996;94:3341–3347.
17.
Nishikawa Y, Stepp DW, Chilian WM: Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 2000;279:H459–H465.
18.
Schildmeyer LA, Bryan RM Jr: Effect of NO on EDHF response in rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 2002;282:H734–H738.
19.
Welsh DG, Segal SS: Role of EDHF in conduction of vasodilation along hamster cheek pouch arterioles in vivo. Am J Physiol Heart Circ Physiol 2000;278:H1832–H1839.
20.
Harder DR, Campbell WB, Roman RJ: Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res 1995;32:79–92.
21.
Hein TW, Liao JC, Kuo L: oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol 2000;278:H175–H183.
22.
Doyle MP, Duling BR: Acetylcholine induces conducted vasodilation by nitric oxide-dependent and -independent mechanisms. Am J Physiol Heart Circ Physiol 1997;272:H1364–H1371.
23.
Ungvari Z, Sun D, Huang A, Kaley G, Koller A: Role of endothelial [Ca2+]i in activation of eNOS in pressurized arterioles by agonists and wall shear stress. Am J Physiol Heart Circ Physiol 2001;281:H606–H612.
24.
De Wit C, Esser N, Lehr HA, Bolz SS, Pohl U: Pentobarbital-sensitive EDHF comediates ACh-induced arteriolar dilation in the hamster microcirculation. Am J Physiol Heart Circ Physiol 1999;276:H1527–H1534.
25.
Hoepfl B, Rodenwaldt B, Pohl U, De Wit C: EDHF, but not NO or prostaglandins, is critical to evoke a conducted dilation upon ACh in hamster arterioles. Am J Physiol Heart Circ Physiol 2002;283:H996–H1004.
26.
Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH: EDHF: Bringing the concepts together. Trends Pharmacol Sci 2002;23:374–308.
27.
Batenburg WW, Popp R, Fleming I, de Vries R, Garrends IM, Saxena PR, Jan Danser AH: Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF. Br J Pharmacol 2004;142:125–135.
28.
Emerson GG, Segal SS: Electrical coupling between endothelial cells and smooth muscle cells in hamster feed arteries: Role in vasomotor control. Circ Res 2000;87:474–479.
29.
Sandow SL, Hill CE: Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses. Circ Res 2000;86:341–346.
30.
Yamamoto Y, Imaeda K, Suzuki H: Endothelium-dependent hyperpolarization and intercellular electrical coupling in guinea-pig mesenteric arterioles. J Physiol 1999;514:505–513.
31.
Yashiro Y, Duling BR: Integrated Ca2+ signaling between smooth muscle and endothelium of resistance vessels. Circ Res 2000;87:1048–1054.
32.
Griffith TM: Endothelium-dependent smooth muscle hyperpolarization: Do gap junctions provide a unifying hypothesis. Br J Pharmacol 2004;141:881–903.
33.
Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ: Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663–1671.
34.
O’Neill WC: Flow-mediated NO release from endothelial cells is independent of K+ channel activation or intracellular Ca2+. Am J Physiol Cell Physiol 1995;269:C863-C869.
35.
Murphy ME, Brayden JE: Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol 1995;486:47–58.
36.
Schmidt HHHW, Lohmann SM, Walter U: The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993;1178:153–175.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.